Influence of autologous blood transfusion on natural killer and lymphokine-activated killer cell activities in cancer surgery. 1997

M M Heiss, and K Fasol-Merten, and H Allgayer, and M A Ströhlein, and A Tarabichi, and S Wallner, and H I Eissner, and K W Jauch, and F W Schildberg
Department of Surgery, Klinikum Grosshadern, Ludwig Maximilians University, Munich, Germany.

OBJECTIVE Immunosuppression associated with blood transfusion may influence postoperative infection rates. It may also affect the prognosis of patients treated surgically for colorectal cancer. To control this effect, study protocols have applied autologous blood donation programs, which are thought to be immunologically neutral. However, evidence has emerged that blood donation itself might have suppressive effects on natural killer (NK) cell activities. At present, there are no data available on the effects of autologous blood transfusion on NK or lymphokine-activated killer (LAK) cells. This might be of interest as LAK cells may be active in tumor control. METHODS 26 patients who underwent surgical resection for colorectal cancer, were assigned at random into two groups: (1) autologous blood donation and transfusion, or (2) allogeneic blood transfusion. NK and LAK activities were determined before blood donation, at surgery, and on the 3rd and 8th postoperative day. RESULTS Blood donation induced a small decrease in NK and LAK activities. The postoperative courses of the two groups differed. In the allogeneic group, NK activity (-50%, p = 0.018) and LAK activity decreased (-60.7%, p = 0.043), whereas in the autologous group the decline in LAK was less pronounced (-33.7%, p = 0.091), and their NK activity even increased (+17.4%, p = 0.315). NK activity was modulated differently in the two study groups (0.0036). Differences in LAK activities were found between the 3rd and 8th day postoperatively (p = 0.354). CONCLUSIONS In patients receiving autologous blood transfusion, postoperative suppressed NK and LAK activities were modulated. This implies that autologous blood transfusion is not immunologically neutral, but has an intrinsic immunomodulatory potential.

UI MeSH Term Description Entries
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D001804 Blood Transfusion, Autologous Reinfusion of blood or blood products derived from the patient's own circulation. (Dorland, 27th ed) Autotransfusion,Autologous Blood Transfusion,Autologous Blood Transfusions,Blood Transfusions, Autologous,Transfusion, Autologous Blood,Transfusions, Autologous Blood,Autotransfusions
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic
D015179 Colorectal Neoplasms Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI. Colorectal Cancer,Colorectal Carcinoma,Colorectal Tumors,Neoplasms, Colorectal,Cancer, Colorectal,Cancers, Colorectal,Carcinoma, Colorectal,Carcinomas, Colorectal,Colorectal Cancers,Colorectal Carcinomas,Colorectal Neoplasm,Colorectal Tumor,Neoplasm, Colorectal,Tumor, Colorectal,Tumors, Colorectal

Related Publications

M M Heiss, and K Fasol-Merten, and H Allgayer, and M A Ströhlein, and A Tarabichi, and S Wallner, and H I Eissner, and K W Jauch, and F W Schildberg
August 1993, Transfusion,
M M Heiss, and K Fasol-Merten, and H Allgayer, and M A Ströhlein, and A Tarabichi, and S Wallner, and H I Eissner, and K W Jauch, and F W Schildberg
June 1992, Arthritis and rheumatism,
M M Heiss, and K Fasol-Merten, and H Allgayer, and M A Ströhlein, and A Tarabichi, and S Wallner, and H I Eissner, and K W Jauch, and F W Schildberg
January 1988, Transfusion,
M M Heiss, and K Fasol-Merten, and H Allgayer, and M A Ströhlein, and A Tarabichi, and S Wallner, and H I Eissner, and K W Jauch, and F W Schildberg
January 1995, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
M M Heiss, and K Fasol-Merten, and H Allgayer, and M A Ströhlein, and A Tarabichi, and S Wallner, and H I Eissner, and K W Jauch, and F W Schildberg
April 1996, Environmental health and preventive medicine,
M M Heiss, and K Fasol-Merten, and H Allgayer, and M A Ströhlein, and A Tarabichi, and S Wallner, and H I Eissner, and K W Jauch, and F W Schildberg
April 2001, The Science of the total environment,
M M Heiss, and K Fasol-Merten, and H Allgayer, and M A Ströhlein, and A Tarabichi, and S Wallner, and H I Eissner, and K W Jauch, and F W Schildberg
August 1990, British journal of cancer,
M M Heiss, and K Fasol-Merten, and H Allgayer, and M A Ströhlein, and A Tarabichi, and S Wallner, and H I Eissner, and K W Jauch, and F W Schildberg
January 1989, Seminars in surgical oncology,
M M Heiss, and K Fasol-Merten, and H Allgayer, and M A Ströhlein, and A Tarabichi, and S Wallner, and H I Eissner, and K W Jauch, and F W Schildberg
January 1992, Acta medica Hungarica,
M M Heiss, and K Fasol-Merten, and H Allgayer, and M A Ströhlein, and A Tarabichi, and S Wallner, and H I Eissner, and K W Jauch, and F W Schildberg
June 1982, The Journal of experimental medicine,
Copied contents to your clipboard!